405224-33-1 Usage
Pyrazolo[3,4-c]pyridazin-3-amine derivatives
This compound belongs to a class of chemical compounds that have a pyrazole ring and a pyridazine ring fused together.
Pyrazole ring
A five-membered heterocyclic ring with three carbon atoms and two nitrogen atoms, contributing to the compound's chemical structure and properties.
Pyridazine ring
Another five-membered heterocyclic ring with three carbon atoms and two nitrogen atoms, further contributing to the compound's structure and properties.
Difluorophenyl group
A phenyl group (a six-membered carbon ring with alternating single and double bonds) with two fluorine atoms attached, which may influence the compound's reactivity and biological activity.
Pharmaceutical research and drug development
This compound has potential applications in the development of new drugs due to its unique chemical and biological properties.
Potential applications
The compound may be useful in the treatment of various diseases and conditions, but further research and studies are needed to explore its potential uses and effects.
Check Digit Verification of cas no
The CAS Registry Mumber 405224-33-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,0,5,2,2 and 4 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 405224-33:
(8*4)+(7*0)+(6*5)+(5*2)+(4*2)+(3*4)+(2*3)+(1*3)=101
101 % 10 = 1
So 405224-33-1 is a valid CAS Registry Number.
405224-33-1Relevant articles and documents
Pyrazolopyridines and pyrazolopyridazines as antidabetics
-
Page/Page column 23, (2010/02/05)
The present invention includes compound of formula (I), or a derivative thereof, wherein Y is CH or N; R1 is unsubstituted or substituted alkyl, unsubstituted or substituted cycloalkyl, unsubstituted or substituted alkenyl, unsubstituted or substituted cycloalkenyl, unsubstituted or substituted aryl, aralkyl wherein the aryl and the alkyl moieties may each independently be unsubstituted or substituted, aralkenyl wherein the aryl, and alkenyl moieties may each independently be unsubstituted or substituted, unsubstituted or substituted heterocyclyl, or heterocyclylalkyl wherein the heterocyclyl and the alkyl moieties may each independently be unsubstituted or substituted; and R2 is unsubstituted aryl or unsubstituted or substituted or substituted heteroaryl. Additionally the present invention includes a process for preparing such a compound, a pharmaceutical composition containing such a compound, and the use of such a compound in medicine.
